![](https://news.europawire.eu/wp-content/uploads/2020/10/Aimmune-Therapeutics-now-a-Nestlé-Health-Science-company-144x144.jpg)
(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq: AIMT). The company which specializes in developing and bringing new treatments to people with potentially life-threatening food allergies joins Nestlé … Read the full press release